Please login to the form below

Not currently logged in
Email:
Password:

Patent

This page shows the latest Patent news and features for those working in and with pharma, biotech and healthcare.

AbbVie/Allergan's merger faces public opposition

AbbVie/Allergan's merger faces public opposition

AbbVie defended its position, saying that Allergan adds $16bn in annual revenues that will help the company preserve the bottom line as it prepares for the upcoming loss of US patent

Latest news

More from news
Approximately 68 fully matching, plus 1,533 partially matching documents found.

Latest Intelligence

  • Why everyone in pharma is bending over backwards to be agile Why everyone in pharma is bending over backwards to be agile

    There are many ‘kicks’ facing the industry: loss of patents, changes in regulatory, political and payer environments, not to mention the competitive pressures of smaller, faster competitors.

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    This includes overriding pharma patents – something the group is advocating in relation to three drugs – Vertex’s cystic fibrosis treatment Orkambi, Pfizer’s breast cancer treatment Ibrance and Roche’s breast ... Just Treatment is also urging

  • Combining therapies and combining research Combining therapies and combining research

    Wholly focused on the discovery and development of new antibiotic combinations, it has already registered 128 patents for novel combinations active against highly resistant bacteria.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Alexion is bracing for the patent expiry of its blockbuster Soliris (eculizumab), used to treat paroxysmal nocturnal haemoglobinuria (PNH) and myasthenia gravis, which hit revenues of around $3bn in 2018. ... The world’s biggest selling drug, Humira,

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    A new cliff is looming: Between 2018 and 2025, branded drugs worth more than $250bn in sales will see their patents expire.

More from intelligence
Approximately 2 fully matching, plus 114 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Apex launches Lumentium UK demo experience to pharma market

    Lumentium was created by a team in Madrid. The team has secured worldwide patents on its TableMapping technology.

  • Three strategies for managing loss of exclusivity successfully

    Patent losses could sink Allergan”. “Drug prices to plummet in wave of expiring patents”. ... patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat of job losses and falling share prices.

  • Cello Health Acquire ISS

    The technical service offering includes consultancy at all stages in the regulatory process, support of FDA Advisory Committee meetings, and data provision in legal defence of patent and intellectual property

  • Making a difference with patient support

    This is just one example of how together, Bedrock and Origins deliver truly patent-centric PSPs.

  • 03 Health Services

    How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation. ... The pharma market is about to get busy. 2011–2013 marks a patent cliff, when many big-selling drugs went, or soon will go, off patent.

More from PMHub
Approximately 1 fully matching, plus 40 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics